CTNI-30. A PHASE 2 DOUBLE-BLIND, RANDOMIZED, PROSPECTIVE, PLACEBO CONTROLLED STUDY OF NANO₂TM COMBINED WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: RESTORE
CTNI-30。一项针对新诊断胶质母细胞瘤患者的 NANO₂™ 联合放射治疗和替莫唑胺治疗的 II 期双盲、随机、前瞻性、安慰剂对照研究：RESTOR
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-78014-0
Cordero, Raúl R; Feron, Sarah; Damiani, Alessandro; MacDonell, Shelley; Carrasco, Jorge; Pizarro, Jaime; Karas, Cyrus; Jorquera, Jose; Sepulveda, Edgardo; Cabello, Fernanda; Fernandoy, Francisco; Wang, Chenghao; Khan, Alia L; Casassa, Gino; Lujan, Arturo; Chakrabarti, Jayati; Eschbacher, Jennifer; Zada, Gabriel; Kim, Albert; Little, Andrew; Santagata, Sandro; Zavros, Yana; Badruddoja, Michael A; Placencia, Crystal; Unger, Evan; Gellert, Scott; Stea, Baldassarre; Peters, Katherine B; Kong, Xiao-Tang; Aiken, Robert; Goldin, Caroline; Mahadevan, Daruka; Goldlust, Samuel A
